These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15333681)

  • 1. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin.
    Krishna SM; James S; Kattoor J; Balaram P
    Jpn J Clin Oncol; 2004 Jun; 34(6):307-11. PubMed ID: 15333681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma: Experience from a North Indian tertiary care hospital.
    Biswal D; Brijwal M; Choudhary A; Kakkar A; Pramanik R; Thakar A; Dar L
    Indian J Med Microbiol; 2024; 51():100699. PubMed ID: 39111666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
    J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana.
    Ayee R; Ofori MEO; Tagoe EA; Languon S; Searyoh K; Armooh L; Bilson-Amoah E; Baidoo K; Kitcher E; Wright E; Quaye O
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32708700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
    Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
    Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma.
    Mai S; Zong Y; Zhang M; Zhong B; Lin S
    Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
    Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma.
    Zhang XS; Wang HH; Hu LF; Li A; Zhang RH; Mai HQ; Xia JC; Chen LZ; Zeng YX
    Cancer Lett; 2004 Jul; 211(1):11-8. PubMed ID: 15194212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
    Fung SY; Lam JW; Chan KC
    Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma.
    Tan EL; Selvaratnam G; Kananathan R; Sam CK
    BMC Cancer; 2006 Sep; 6():227. PubMed ID: 16995954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and epstein-barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma.
    Hao SP; Tsang NM; Chang KP
    Laryngoscope; 2004 Nov; 114(11):2027-30. PubMed ID: 15510036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].
    Li XM; Yang CZ; Chen PJ; Su ZL; Song Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Sep; 14(9):400-1. PubMed ID: 12563909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
    Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population.
    Tune CE; Liavaag PG; Freeman JL; van den Brekel MW; Shpitzer T; Kerrebijn JD; Payne D; Irish JC; Ng R; Cheung RK; Dosch HM
    J Natl Cancer Inst; 1999 May; 91(9):796-800. PubMed ID: 10328111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY; Ning S; Arrand JR
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug; 23(4):200-3. PubMed ID: 7805145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.